Supreme Court clarifies valuation of physician samples under Central Excise Act

The Supreme Court resolved conflicting decisions by CESTAT regarding the valuation of goods sold by SPIL as physician samples. The Court clarified that the transaction value between the assessee and distributors, where a price was charged, was crucial for valuation under Section 4(1)(a) of the Central Excise Act. As physician samples were not sold to physicians, Rule 6(b)(ii) of the Valuation Rules did not apply. Consequently, the Court upheld CESTAT's decision, dismissing the Revenue's appeals and affirming the established legal position on the issue.

---

---

Issues:
- Conflict in decisions by Customs, Excise and Service Tax Appellate Tribunal (CESTAT) regarding the 'transaction value' of goods sold by M/s. Sun Pharmaceuticals Industries Limited (SPIL) as physician samples to distributors.
- Interpretation of Section 4(1)(a) of the Central Excise Act, 1944 in relation to the valuation of excisable goods sold by the assessee.
- Application of Central Excise Valuation Rules, 1975 in determining the value of goods sold as physician samples.

Analysis:
The Supreme Court addressed the conflicting decisions of CESTAT regarding the 'transaction value' of goods sold by SPIL as physician samples. The dispute arose as the goods were sold at different prices to distributors and ultimate consumers. The Revenue contended that since physician samples were cleared for free distribution, the value should be determined as per Section 4(1)(b) of the Act, invoking Rule 6(b) of the Rules. However, CESTAT in its judgment dated 10.11.2006 accepted the plea of the assessee, leading to Revenue's appeal in Civil Appeal Nos. 3742-3744 of 2007.

In another appeal, Civil Appeal No. 3263 of 2009, a Show Cause Notice raised similar issues for different periods. The Technical Member of CESTAT held that the price was not the sole consideration as physician samples were meant for free distribution, while the Judicial Member took a contrary view. The Supreme Court found that CESTAT had exceeded the grounds of the Show Cause Notice in its judgment dated 27.02.2009, leading to the allowance of Civil Appeal No. 3263 of 2009.

The central issue revolved around the applicability of Section 4(1)(a) of the Act, which states that the transaction value shall be considered for excisable goods sold by the assessee. The Court emphasized that the transaction between the assessee and distributors, where a price was charged, was crucial for valuation. The Show Cause Notice's reasoning, based on goods not being sold to physicians, was deemed fallacious. Thus, the case fell under Section 4(1)(a), and Rule 6(b)(ii) of the Rules did not apply.

Consequently, the Court upheld the decision of CESTAT dated 10.11.2006, dismissing Civil Appeal Nos. 3742-3744 of 2007. The Court further dismissed all related appeals of the Revenue on the same issue, following the established legal position.

---